Founded in 2013, Bioscan Research operates in Health Tech offering an objective assessment tool designed for early detection of traumatic brain injury in patients at a pre-symptomatic phase. The compa...
Funding stage:
Undisclosed
Last funding:
31/03/2019
Investors
Employee count:
28
Last 90d
28
Last 90d
Web traffic:
992
992
Last 30d
Last 30d
Bioscan Research: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders5
Latest Filing Date30 March 2023- Funding Events12
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Bioscan Research
As of 31 March 2023, Bioscan Research's equity is held by 5 shareholders, with the top three being Shilpa Malik, Anupam Lavania, and Gujarat Foundation For Entrepreneurial Excellence.
Shilpa Malik holds the largest stake in Bioscan Research at 58.1% as of 31 March 2023.
As of 31 March 2023, founders collectively hold 87.1% equity in Bioscan Research.
As of 31 March 2023, investors collectively hold 12.9% equity in Bioscan Research.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links